Member Info for Nicksmith123

Hi James - we possibly knew this, as the 1.50 was just an uncrossing.

I think it will move further south, but unless you need your money over the next 3 weeks, i don't think it's what we should have our eye on (trust me, i know it's hard to see money deteriorate!).

Hi Num4 - i couldnt agree more. If as many shareholders write to them and tell them this, hopefully some attention will be paid...?
Seen your tweet... dont expect a response.

For investors that are currently being burnt... it's of course your money, but don't forget that your investment into SAR shouldn't have been about COVID. That was never the key for us. We have more announcements due which is what all SAR holders should be excited about. COVID just helped the momentum (which i know we've lost for now..) but really we are about TYK2.

Terrytibbs - you seem like a nervous holder. This is aim and there will be ups and downs, but both NUM4 and THOTH2 (respected LTHs and not rampers) have larger holdings and have not sold up. Waiting 6 months is not that long for investors...

BIGGER THINGS COMING.... so yes there will be price deterioration... not ideal (which is why i suggest we ask SAR to keep up momentum by having truthful updates) .... but don't necessarily worry about the price drop when we're waiting for more key news....

PS: Fadec - while no one probably predicted the crash across all bio firms and this of course was the major play.... i have to admit you were right about the 1.38 call!

HI SOG - i agree that most biotech firms have crashed. The vaccine news was over played for me. In fact even Pfizer are downplaying it now.

However, SAR is more than covid (this was a side play). The difference is that while most COVID stocks will see recovery over the coming week, i don't believe SAR will. They don't have the same investor attention. This is why their PR needs to go into overdrive. Losing this much of your market cap is not good enough and we should be out there giving ourselves a real push.

I will say again - as much as we think the science will do the talking, momentum and running the business commercially is key to driving share price. We need a strong base to build momentum from.

I know others believe we are being manipulated by MM and there may be some of this, but no where near the extent that people think, in my opinion. SAR need to come out fighting (look at AVACTA tweeting away, ODX same, etc etc). We don't have the eye of the investor and we should be doing everything we can to draw attention to ourselves...especially when we are not all about COVID and so much more!

SARs tweet is about how well other companies are doing with their trials... !

Fadec - i understand what you are saying. However, similar to you quoting how the majority of pre clinical studies fail.... well the same can be said for charts and stock figure assumptions. Stock price charts are very rarely correct. They can plug in all the figures, candlelight’s can be drawn, but it does not take into account sentiment and human judgement. In fact, your point about quoteddata at 1.38 proves exactly that. We aren’t at that price and i don’t envisage us back there.

Stock price is based on what investors believe in. Sareum has a hot property ... and it is about right time right place. Add into the mix covid which is a bonus for Sar.

Most, including yourself i think, believe in the science. However, as i have continually said, it isn’t always about this. That’s why PR is key, along with having the right type of investors, etc.

Momentum is what can drive a share price. I think we have this on our side and hope we can keep it up.

Thanks Num4 much appreciated.

Tim stated in the a investor meets that the big pharmas still wanted to see more progression with TYK2 before discussing takeover/licencing. Where do you believe we need to be in regards to stages, before a "pfizer" will realistically want to push for a takeover?

They've certainly been keen to put out some kind of Sareum tweet over the last week.... or am i reading too much into it?!

Bridges... i'm looking forward to your wave 5! when's that coming?! : )

RMM - we are missing an "arix bioscience" . These kind of companies have a crucial role.

It's what we need if SAR are serious about selling up.

Does anyone know when CRT can pull SRA737 back from Sierra? Is it at any time?

Personally i don't think Sierra want to move forward with SRA737, but if they can ponce off CRT with a "looking for funding" as long as possible, it then stops it going into someone else's hands.

Aberystwyth - yes you're right. I did just get easily pleased there. Still, it's the quckest cut and paste i've seen them do.

haha can't knock their PR department for that swift action!

Clogs and wheels are turning....

RMM - surely you can't believe this is all down to MM manipulation? They don''t have powers to manipulate the share price to that effect. They may be able to hold it down for an hour of the day etc but in general there are strict regulations to abide by. They are also not allowed to hold more than 10% in non traded shares (nor would they want to).
Yes after £100m market cap it can move to SETS, but this can have MMs involved too, just not as directly as it does now.

The bigger picture is that the share price is dropping as that's pretty much what happens when a company the size of SAR stops getting attention. Day traders and short term investors move out.

In fairness, there's a few price points to consolidate at and the price drops are fulfilling this. One can see this sort of pricing action regularly on AIM. It even happens to companies like NCYT.

Shareholders here just need to remember that there is bigger and better things lined up for SAR. We have so much news pending. This has been highlighted very aptly by SOG in his post today. It's EXCITING!

The science is good and like many of you, i strongly believe it will come good. I fully agree with THOTH2/NUM4/STONEY/SOG et al, that we have a product that is in a market space which is HOT and actually it's irrelevant if other competitors are there too, as there is enough space for SAR in there.

My only wish would be that they would be more effective at PR. With the number of shares in play, it is vital to have effective communication with shareholders and bring in investor confidence. NCYT, ODX, VELA, AVACTA - all blue today. Covid stocks. Yet SAREUM isn't even known to investors as a covid stock. This isn't effective work by the company.

How can we bring SAREUM to the attention of those writing about covid stocks?

The problem with Sareum is that their PR is appalling.

Vela tech is trading around 23% higher as they got a few mentions in covid based articles over the weekend.

We should also be appearing in these articles but don’t! This slowly leads to a deterioration in share price until the next RNS.
I understand some are stating the science will eventually do the talking, but there really would be no harm in keeping up momentum!!

Any shareholders who know science journalists /press contacts... let’s start mentioning Sareum. There can’t be any harm in trying to create our own PR while we wait...!

Fadec - thanks for your response. It is much appreciated.
I think it's vital we can keep a balanced view on the board, even when it is negative for SAR. I think in the long term it can only help both shareholders and the company to have balanced effective research.

NUM4/Thoth2/Damion/RMM - it would be good to have your views on Fadec's take.

Hi Fadec, so in your opinion, are you concerned about Nimbus/BMY tyk2? As a sareum shareholder?

on Sierra, would an increase in share price relate to SRA737? In general if a company is allocating payments for royalty, this hits cash flow, which in the short term leads to a fall in share price. Markets don’t like investments in the short term.
This of course will change once they have something ready to go with SRA737.

or am i reading it wrong?

Hi RMM -that's a good post. Why do you believe we're not a 5pence - where we should be as yet? Sometimes (as we have seen with others in biotech) it can take a week or two for it to filter in...

We saw this kind of pricing action yesterday, before it finished blue again.

Just hold your horses, it does take a few days for news to sink in, for short traders to move out etc.

What we need now is for a really good informative board to encourage new investors / keep confident investors who have bought in the last few days. The difference with SAR and many other companies is the level of PI it has and the number of shares.

The LTHs are always going on about the science...so bring the science to the board. Let it do the talking for now.

See the NCYT board - while they constantly have rampers/derampers, there are some really good knowledgeable investors on there that bring confidence to the board, even when they are red. We need to be able to do the same.

I am hoping the likes of Thoth2, RMM, NUM4, BOILB, KRONE, and so on can run this board (like they were previously) with good informative knowledge. You might think this is new investors piggy backing on LTHs... you're right. But new investors that become LTHs will be what keeps stability in your share price.

HI Earth - agree, but a comparison to NCYT is not correct. This is based on possibilities rather than physical orders. If BIG PHARMA believe SAR have something, it is worth much more than NCYT. A cure for cancer. A treatment for covid.

It is about possibilities and hence NCYT is not really a relevant comparison.